Legend Biotech Corporation (FRA:9LB)
Germany · Delayed Price · Currency is EUR 16.90
+0.10 (0.60%)
At close: Oct 23, 2026
Legend Biotech Market Cap
Legend Biotech has a market cap or net worth of €3.33 billion as of October 23, 2026. Its market cap has decreased by 34.67% in one year.
Market Cap
3.33B
Enterprise Value
2.72B
Revenue
1.11B
Global Rank
n/a
Country Rank
n/a
PE Ratio
n/a
ChartMarket Cap Chart
Since June 5, 2020, Legend Biotech's market cap has decreased from 4.23B to 3.33B, a decrease of -21.15%. That is a compound annual growth rate of -3.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 3.33B | -2.49% |
| Dec 31, 2025 | 3.42B | -40.69% |
| Dec 31, 2024 | 5.77B | -41.73% |
| Dec 29, 2023 | 9.90B | 26.55% |
| Dec 30, 2022 | 7.82B | 23.93% |
| Dec 31, 2021 | 6.31B | 106.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 62.30B |
| Siemens Healthineers AG | 46.59B |
| Bayer Aktiengesellschaft | 43.21B |
| Fresenius SE & Co. KGaA | 25.97B |
| SCHOTT Pharma AG & Co. KGaA | 3.87B |
| Fielmann Group AG | 3.34B |
| Ottobock SE & Co. KGaA | 3.15B |
| Carl Zeiss Meditec AG | 3.11B |